Viridian Pharma, now part of Martindale Pharma, was established in the UK in 2002 to develop and market niche pharmaceutical products for hospital use.
Martindale Pharma, headquartered in the UK, is a leading international specialty pharmaceutical company providing essential medicines to over 20 countries around the world. We operate principally in the UK, the Middle East, Northern Europe as well as Africa and Asia-Pacific. We are the market leaders in several classes of medicines in these markets.
Martindale Pharma's strategy is to build leading positions in defined business segments where there is a high unmet medical need and a demand for improved product presentations. Our current product range is focused on Emergency Care, Hospital-initiated Medicines, Opioid Addiction, Ophthalmics and Unlicensed Medicines (also called “Specials”).
With a history of working in the pharmaceutical industry for over 150 years, Martindale Pharma has an unmatched positive reputation for the development, manufacturing and commercialisation of medicines to treat serious illnesses. We pride ourselves on a commitment to operate to the highest quality standards, leveraging our UK base and expertise in pharmaceutical production. We create and supply products that add value to healthcare systems, delivering excellent customer service and offering a comprehensive portfolio of products in the business segments in which we operate.
Our mission is to “make lives better”, not only the patients who ultimately benefit from our products, but healthcare professionals who care for patients who receive our products, our corporate partners and employees.